Prefilled Syringes Industry

The report "Prefilled Syringes Market by Type (Conventional, Safety), Material (Glass Prefilled Syringe, Plastic), Design (Single-Chamber Prefilled Syringe, Dual-Chamber), Application (Diabetes, Cancer, and Rheumatoid Arthritis), & Region - Global Forecast to 2030", is projected to reach USD 13.1 billion in 2030 from USD 7.1 billion in 2024, at a CAGR of 10.8% between 2024 and 2030.

Browse 243 market data Tables and 59 Figures spread through 292 Pages and in-depth TOC on "Prefilled Syringes Market by Type (Conventional, Safety), Material (Glass Prefilled Syringe, Plastic), Design (Single-Chamber Prefilled Syringe, Dual-Chamber), Application (Diabetes, Cancer, and Rheumatoid Arthritis), & Region - Global Forecast to 2030 "
View detailed Table of Content here - https://www.marketsandmarkets.com/Market-Reports/prefilled-syringes-market-16618331.html

The growth of the prefilled syringe market is primarily driven by the rising prevalence of chronic diseases requiring long-term therapies, coupled with the growing elderly population globally, and the increasing adoption of biological drugs, which often require precise dosing and administration. However, stringent regulations for approval processes and safety issues associated with pre-filled syringes can affect market growth, requiring continuous innovation and rigorous testing to overcome these barriers.

Conventional prefilled syringes segment is expected to account for the largest share, by type in the prefilled syringes market during the forecast period.

The conventional prefilled syringe segment holds the highest share in the prefilled syringe market due to its widespread adoption across various therapeutic areas. These syringes are pre-filled with a specific dosage of medication, ensuring convenience and precise dosing for healthcare providers and patients. They are favored for their ease of use, reduced risk of contamination, and compatibility with a wide range of drugs. This segment's dominance is driven by its versatility and the established manufacturing processes that support large-scale production to meet global healthcare demands effectively.

Glass prefilled syringes segment is expected to account for the largest share, by material  in the prefilled syringes market during the forecast period.

The glass prefilled syringe segment holds the highest share in the prefilled syringe market primarily due to its superior material properties and suitability for sensitive drug formulations. Glass syringes offer advantages such as inertness, which minimizes the risk of drug interaction or leaching, making them ideal for biologics, vaccines, and other complex formulations. They are also preferred for their transparency, which allows visual inspection of the drug and facilitates accurate dosage administration. Despite being more fragile than plastic, advancements in glass technology have enhanced their durability and safety, reinforcing their dominant position in the market.

Single-chamber prefilled syringes segment is expected to account for the largest share, by design  in the prefilled syringes market during the forecast period.

The single-chamber prefilled syringe segment commands the highest share in the prefilled syringe market because of its simplicity and cost-effectiveness in drug delivery. These syringes contain a single compartment pre-filled with a specific medication, making them straightforward to manufacture and use. They are widely employed across various therapeutic applications, ranging from vaccines to insulin delivery, due to their ease of handling and reduced risk of medication errors.

Cancer segment is expected to account for the largest share, by application in the prefilled syringes market during the forecast period.

The cancer segment holds the highest share in the prefilled syringe market owing to the increasing prevalence of cancer worldwide and the rising demand for precise and targeted drug delivery systems. Prefilled syringes offer significant advantages in oncology treatments, including accurate dosing, reduced risk of contamination, and enhanced patient compliance. They are used for delivering chemotherapy drugs, monoclonal antibodies, and supportive care medications, facilitating personalized treatment regimens and improving patient outcomes. This segment's dominance reflects the critical role of prefilled syringes in supporting advanced cancer therapies and the continuous innovation aimed at addressing specific oncological challenges.

 In 2023, North America accounted for the largest share of the prefilled syringes market.

The prefilled syringes market is segmented into five major regions, namely, North America, Europe, Asia Pacific (APAC), Latin America, Middle East and Africa, and the GCC Countries.

North America holds the highest share in the prefilled syringe market due to robust healthcare infrastructure, high adoption rates of advanced medical technologies, and significant investments in pharmaceutical research and development. The region's leading position is supported by stringent regulatory standards that favor the use of prefilled syringes for safe and effective drug delivery. Additionally, increasing prevalence of chronic diseases drive the demand for prefilled syringes in North America. The presence of major pharmaceutical companies and biotechnology firms further stimulates market growth, ensuring a strong market foothold in this region.

Key Market Players :

The key players in the global prefilled syringes market are BD (US), Gerresheimer AG (Germany), SCHOTT (Germany), and West Pharmaceutical Services, Inc. (US), AptarGroup Inc. (US), Nipro (Japan), Baxter (US), Owen Mumford Ltd. (UK), Weigao Meidcal international Co., Ltd. (China), Credence MedSystems, Inc.(US), Novartis AG (Switzerland), Stevanato Group (Italy), Polymedicure (India), MedXL (Canada), Sharps Technology, Inc.(US), Fresenius Kabi (US), DBM S.R.L. (Italy), Taisei Kako Co.,Ltd (Japan), Shandong Province Medicinal Glass Co., Ltd.(China), SHIN YAN SHENO PRECISION INDUSTRIAL CO., LTD (Japan), J.O. PHARMA CO., LTD. (Japan), BMIKOREA (Korea), B. Braun SE ( Germany), and Al Shifa Medical Products Co. (Saudi Arabia).

Don’t miss out on business opportunities in Prefilled Syringes Market. Speak to our analyst and gain crucial industry insights that will help your business grow.

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
[email protected]